Coagulation disorders and vascular diseases of the liver in patients with COVID-19

被引：2
|
作者：
Tsafaridou, Maria [1 ]
Maniadaki, Ilianna [2 ]
Koutroubakis, Ioannis [1 ]
Samonakis, Dimitrios N. [1 ]
机构：
[1] Univ Hosp Heraklion, Dept Gastroenterol & Hepatol, Bldg A,4th floor, Iraklion 71110, Greece
[2] Univ Hosp Heraklion, Dept Pediat, Iraklion, Greece
来源：
CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2022年 / 8卷 / 02期
关键词：
COVID-19; liver; thrombosis; portal vein; PORTAL-VEIN THROMBOSIS; SARS-COV-2; INFECTION; INJURY;
D O I：
10.5114/ceh.2022.116972
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 infection. Amongst the major pathophysiological mechanisms, the generation of a prothrombotic environment is increasingly recognized and is related to thromboembolic events. We conducted a review of the literature and summarized the coagulation disorders in the liver in patients with COVID-19.
引用
收藏
页码：97 / 102
页数：6
相关论文
共 50 条
  • [41] COVID-19 in Patients with Hematologic Diseases
    Casetti, Ilaria Carola
    Borsani, Oscar
    Rumi, Elisa
    BIOMEDICINES, 2022, 10 (12)
  • [42] COVID-19 IN PATIENTS WITH CONGENITAL BLEEDING DISORDERS IN RUSSIA
    Yakovleva, E. V.
    Vybornykh, D. E.
    Gemdzhian, E. G.
    Zozulya, N. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2023, 68 (02): : 218 - 227
  • [43] Potential mechanisms of cerebrovascular diseases in COVID-19 patients
    Lou, Manxue
    Yuan, Dezhi
    Liao, Shengtao
    Tong, Linyan
    Li, Jinfang
    JOURNAL OF NEUROVIROLOGY, 2021, 27 (01) : 35 - 51
  • [44] Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
    Gabrielli, Maurizio
    Franza, Laura
    Esperide, Alessandra
    Gasparrini, Irene
    Gasbarrini, Antonio
    Franceschi, Francesco
    VACCINES, 2022, 10 (02)
  • [45] COVID-19 in patients with cardiovascular diseases
    Hulot, Jean-Sebastien
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (04) : 225 - 226
  • [46] COVID-19 und LebererkrankungenCOVID-19 and liver diseases
    Stephan Schmid
    Arne Kandulski
    Martina Müller-Schilling
    Die Gastroenterologie, 2023, 18 (2) : 107 - 114
  • [47] Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue
    Kaviani, Maryam
    Keshtkar, Somayeh
    Soleimanian, Saeede
    Sabet Sarvestani, Fatemeh
    Azarpira, Negar
    Pakbaz, Sara
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [48] Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19
    Tuculeanu, Georgeana
    Barbu, Ecaterina Constanta
    Lazar, Mihai
    Chitu-Tisu, Cristina Emilia
    Moisa, Emanuel
    Negoita, Silvius Ioan
    Ion, Daniela Adriana
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [49] Thrombotic sinusoiditis and local diffuse intrasinusoidal coagulation in the liver of subjects affected by COVID-19: the evidence from histology and scanning electron microscopy
    Fanni, D.
    Cerrone, G.
    Saba, L.
    Demontis, R.
    Congiu, T.
    Piras, M.
    Gerosa, C.
    Suri, J.
    Coni, P.
    Caddori, A.
    Piga, M.
    Mancosu, G.
    Barcellona, D.
    Ravarino, A.
    Chighine, A.
    Cau, F.
    Scano, A.
    Balestrieri, A.
    Coghe, F.
    Orru, G.
    Van Eyken, P.
    La Nasa, G.
    D'Aloia, E.
    Marongiu, F.
    Faa, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (19) : 5904 - 5912
  • [50] Endocrine Disorders and COVID-19
    Oguz, Seda Hanife
    Yildiz, Bulent Okan
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 75 - 88
12345